Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lamotrigine for Ménière's Disease: a Double-blind, Placebo-controlled Pilot Study

NCT02158585 is registered in ClinicalTrials.gov with Dent Neuroscience Research Center as lead sponsor.

NCT NCT02158585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02158585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lamotrigine for Ménière's Disease: a Double-blind, Placebo-controlled Pilot Study
Lead sponsor
Dent Neuroscience Research Center
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2014
Completion date
March 31, 2017
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

meniere's disease, ménière's vertigo, vertigo, aural, vertigo, intermittent